This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,609.40 firm fixed price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC enables efficient government procurement of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract does not have a set-aside designation, indicating open competition. The award date is November 15, 2024, with an ultimate completion date of November 18, 2024, and is being performed in Conshohocken, Pennsylvania.
Generated 2/14/25, 9:20 AM